Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 914 | 934 | 7,391 | 2,221 | 944 |
| Gross Profit | 914 | 934 | 7,391 | 2,221 | 944 |
| Operating Expenses | 64,953 | 72,503 | 65,486 | 62,351 | 55,858 |
| Operating Income | -64,039 | -71,569 | -58,095 | -60,130 | -54,914 |
| Other Income | -9,772 | -13,598 | -13,751 | -13,223 | -12,556 |
| Pre-tax Income | -73,811 | -85,167 | -71,846 | -73,353 | -67,470 |
| Income Tax | 31 | 218 | N/A | -653 | -15 |
| Net Income Continuous | -73,842 | -85,385 | -71,846 | -72,700 | -67,455 |
| Net Income | $-73,842 | $-85,385 | $-71,846 | $-72,700 | $-67,455 |
| EPS Basic Total Ops | -2.03 | -2.36 | -1.97 | -2.00 | -1.86 |
| EPS Basic Continuous Ops | -2.03 | -2.35 | -1.97 | -2.00 | -1.86 |
| EPS Diluted Total Ops | -2.03 | -2.36 | -1.97 | -2.00 | -1.86 |
| EPS Diluted Continuous Ops | -2.03 | -2.35 | -1.97 | -2.00 | -1.86 |
| EPS Diluted Before Non-Recurring Items | -2.03 | -2.35 | -1.97 | N/A | N/A |
| EBITDA(a) | $-63,731 | $-70,005 | $-55,941 | $-58,070 | $-52,926 |